vs
ZoomInfo Technologies Inc.（GTM）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是ZoomInfo Technologies Inc.的1.9倍（$622.0M vs $319.1M），Royalty Pharma plc净利率更高（34.4% vs 10.9%，领先23.6%），Royalty Pharma plc同比增速更快（4.8% vs 3.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.4%）
ZoomInfo Technologies Inc.是美国合规注册的数据服务商，通过数据采集、网页抓取等多元渠道汇总公开及非公开个人数据，同时收集企业、部门等商业主体信息，面向企业客户提供相关数据产品，助力客户开展精准营销等业务活动。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GTM vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$319.1M
营收增速更快
RPRX
高出1.5%
3.2%
净利率更高
RPRX
高出23.6%
10.9%
两年增速更快
RPRX
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $319.1M | $622.0M |
| 净利润 | $34.7M | $214.2M |
| 毛利率 | 84.0% | — |
| 营业利润率 | 17.0% | 62.4% |
| 净利率 | 10.9% | 34.4% |
| 营收同比 | 3.2% | 4.8% |
| 净利润同比 | 137.7% | 2.9% |
| 每股收益（稀释后） | $0.11 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTMRPRX
| Q4 25 | $319.1M | $622.0M | ||
| Q3 25 | $318.0M | $609.3M | ||
| Q2 25 | $306.7M | $578.7M | ||
| Q1 25 | $305.7M | $568.2M | ||
| Q4 24 | $309.1M | $593.6M | ||
| Q3 24 | $303.6M | $564.7M | ||
| Q2 24 | $291.5M | $537.3M | ||
| Q1 24 | $310.1M | $568.0M |
净利润GTMRPRX
| Q4 25 | $34.7M | $214.2M | ||
| Q3 25 | $38.7M | $288.2M | ||
| Q2 25 | $24.0M | $30.2M | ||
| Q1 25 | $26.8M | $238.3M | ||
| Q4 24 | $14.6M | $208.2M | ||
| Q3 24 | $23.8M | $544.0M | ||
| Q2 24 | $-24.4M | $102.0M | ||
| Q1 24 | $15.1M | $4.8M |
毛利率GTMRPRX
| Q4 25 | 84.0% | — | ||
| Q3 25 | 83.7% | — | ||
| Q2 25 | 83.9% | — | ||
| Q1 25 | 84.5% | — | ||
| Q4 24 | 82.8% | — | ||
| Q3 24 | 84.4% | — | ||
| Q2 24 | 84.3% | — | ||
| Q1 24 | 86.0% | — |
营业利润率GTMRPRX
| Q4 25 | 17.0% | 62.4% | ||
| Q3 25 | 21.2% | 70.1% | ||
| Q2 25 | 17.5% | 36.3% | ||
| Q1 25 | 16.5% | 94.0% | ||
| Q4 24 | 10.0% | 60.9% | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | -6.9% | 50.2% | ||
| Q1 24 | 13.9% | -13.0% |
净利率GTMRPRX
| Q4 25 | 10.9% | 34.4% | ||
| Q3 25 | 12.2% | 47.3% | ||
| Q2 25 | 7.8% | 5.2% | ||
| Q1 25 | 8.8% | 41.9% | ||
| Q4 24 | 4.7% | 35.1% | ||
| Q3 24 | 7.8% | 96.3% | ||
| Q2 24 | -8.4% | 19.0% | ||
| Q1 24 | 4.9% | 0.8% |
每股收益（稀释后）GTMRPRX
| Q4 25 | $0.11 | $0.49 | ||
| Q3 25 | $0.12 | $0.67 | ||
| Q2 25 | $0.07 | $0.07 | ||
| Q1 25 | $0.08 | $0.55 | ||
| Q4 24 | $0.04 | $0.46 | ||
| Q3 24 | $0.07 | $1.21 | ||
| Q2 24 | $-0.07 | $0.23 | ||
| Q1 24 | $0.04 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $179.9M | $618.7M |
| 总债务越低越好 | $1.3B | $9.0B |
| 股东权益账面价值 | $1.5B | $9.7B |
| 总资产 | $6.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.88× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GTMRPRX
| Q4 25 | $179.9M | $618.7M | ||
| Q3 25 | $135.0M | $938.9M | ||
| Q2 25 | $176.9M | $631.9M | ||
| Q1 25 | $140.5M | $1.1B | ||
| Q4 24 | $139.9M | $929.0M | ||
| Q3 24 | $147.7M | $950.1M | ||
| Q2 24 | $399.3M | $1.8B | ||
| Q1 24 | $440.2M | $843.0M |
总债务GTMRPRX
| Q4 25 | $1.3B | $9.0B | ||
| Q3 25 | $1.3B | $8.9B | ||
| Q2 25 | $1.3B | $8.0B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.2B | $7.6B | ||
| Q1 24 | $1.2B | $6.1B |
股东权益GTMRPRX
| Q4 25 | $1.5B | $9.7B | ||
| Q3 25 | $1.5B | $9.6B | ||
| Q2 25 | $1.6B | $9.5B | ||
| Q1 25 | $1.6B | $9.8B | ||
| Q4 24 | $1.7B | $10.3B | ||
| Q3 24 | $1.7B | $10.3B | ||
| Q2 24 | $1.9B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产GTMRPRX
| Q4 25 | $6.4B | $19.6B | ||
| Q3 25 | $6.4B | $19.3B | ||
| Q2 25 | $6.5B | $18.3B | ||
| Q1 25 | $6.4B | $17.6B | ||
| Q4 24 | $6.5B | $18.2B | ||
| Q3 24 | $6.4B | $18.0B | ||
| Q2 24 | $6.7B | $17.7B | ||
| Q1 24 | $6.8B | $16.1B |
负债/权益比GTMRPRX
| Q4 25 | 0.88× | 0.92× | ||
| Q3 25 | 0.87× | 0.93× | ||
| Q2 25 | 0.85× | 0.84× | ||
| Q1 25 | 0.75× | 0.78× | ||
| Q4 24 | 0.72× | 0.74× | ||
| Q3 24 | 0.74× | 0.74× | ||
| Q2 24 | 0.66× | 0.78× | ||
| Q1 24 | 0.61× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $143.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $127.1M | — |
| 自由现金流率自由现金流/营收 | 39.8% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | 4.14× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $389.3M | — |
8季度趋势，按日历期对齐
经营现金流GTMRPRX
| Q4 25 | $143.5M | $827.1M | ||
| Q3 25 | $93.8M | $702.6M | ||
| Q2 25 | $108.9M | $364.0M | ||
| Q1 25 | $119.2M | $596.1M | ||
| Q4 24 | $109.0M | $742.5M | ||
| Q3 24 | $18.2M | $703.6M | ||
| Q2 24 | $126.3M | $658.2M | ||
| Q1 24 | $115.9M | $664.6M |
自由现金流GTMRPRX
| Q4 25 | $127.1M | — | ||
| Q3 25 | $70.9M | — | ||
| Q2 25 | $86.9M | — | ||
| Q1 25 | $104.4M | — | ||
| Q4 24 | $85.6M | — | ||
| Q3 24 | $600.0K | — | ||
| Q2 24 | $115.2M | — | ||
| Q1 24 | $103.1M | — |
自由现金流率GTMRPRX
| Q4 25 | 39.8% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 28.3% | — | ||
| Q1 25 | 34.2% | — | ||
| Q4 24 | 27.7% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 39.5% | — | ||
| Q1 24 | 33.2% | — |
资本支出强度GTMRPRX
| Q4 25 | 5.1% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 7.6% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 4.1% | — |
现金转化率GTMRPRX
| Q4 25 | 4.14× | 3.86× | ||
| Q3 25 | 2.42× | 2.44× | ||
| Q2 25 | 4.54× | 12.06× | ||
| Q1 25 | 4.45× | 2.50× | ||
| Q4 24 | 7.47× | 3.57× | ||
| Q3 24 | 0.76× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 7.68× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTM
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
